Symbol Name ID |
Adam22
a disintegrin and metallopeptidase domain 22 MGI:1340046 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Adam22tm1.1Mejr/Adam22tm1.1Mejr H2az2Tg(Wnt1-cre)11Rth/H2az2+ involves: 129S4/SvJaeSor * C57BL/6J * CBA/J |
abnormal myelination | J:158973 |
abnormal neuron morphology | J:158973 | |
Adam22tm1.1Mejr/Adam22tm1.1Mejr Tg(Dhh-cre)1Mejr/0 involves: 129S4/SvJaeSor * FVB/N |
normal nervous system phenotype | J:158973 |
Adam22tm1Sag/Adam22tm1Sag either: B6.Cg-Adam22tm1Sag or (involves: C57BL/6 * C57BL/6N * CBA) |
abnormal myelination | J:99692 |
abnormal Schwann cell morphology | J:99692 | |
ataxia | J:99692 | |
convulsive seizures | J:99692 | |
decreased body size | J:99692 | |
decreased body weight | J:99692 | |
postnatal lethality, complete penetrance | J:99692 | |
Adam22tm1Sag/Adam22tm1Sag involves: C57BL/6 * CBA |
abnormal glial cell morphology | J:166449 |
abnormal neuron morphology | J:158973 | |
decreased body weight | J:166449 | |
demyelination | J:158973, J:166449 | |
neonatal lethality, incomplete penetrance | J:166449 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/17/2024 MGI 6.24 |
|
|